Results 141 to 150 of about 4,836 (184)

Biologics and small molecules for perianal Crohn's disease: a systematic review and meta-analyses of randomized placebo-controlled trials. [PDF]

open access: yesInflamm Bowel Dis
Yuan Y   +9 more
europepmc   +1 more source

Cost-Effectiveness Analysis of Bimekizumab against Interleukin-23 Inhibitors in Patients with Plaque Psoriasis in Japan. [PDF]

open access: yesDermatol Ther (Heidelb)
Igarashi A   +6 more
europepmc   +1 more source

Real-world effectiveness of guselkumab for induction of remission in Crohn's disease: a prospective multicenter cohort study with propensity score-matched comparison to risankizumab. [PDF]

open access: yesCrohns Colitis 360
Al Hosani M   +12 more
europepmc   +1 more source

Efficacy of Risankizumab in Moderate to Severe Psoriasis Considering Body Mass Index: A Scoping Review. [PDF]

open access: yesCureus
Sarmiento K   +6 more
europepmc   +1 more source

Interleukin-23 Inhibitors in Inflammatory Bowel Disease. [PDF]

open access: yesBioDrugs
Puca P   +8 more
europepmc   +1 more source

Asian Pacific Association of Gastroenterology (APAGE) Clinical Practice Guidelines on the Use of Small Molecules and IL-23 p19 Inhibitors in Ulcerative Colitis and Crohn's Disease. [PDF]

open access: yesJ Gastroenterol Hepatol
Ooi CJ   +34 more
europepmc   +1 more source

Matching-Adjusted Indirect Comparison of Risankizumab Versus Icotrokinra in Adult Patients with Moderate-to-Severe Plaque Psoriasis. [PDF]

open access: yesDermatol Ther (Heidelb)
Crowley J   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy